CanSino Biologics Management
Management criteria checks 4/4
CanSino Biologics' CEO is Xuefeng Yu, appointed in Jan 2009, has a tenure of 15.83 years. total yearly compensation is CN¥3.97M, comprised of 64.1% salary and 35.9% bonuses, including company stock and options. directly owns 11.96% of the company’s shares, worth HK$1.34B. The average tenure of the management team and the board of directors is 6.8 years and 3.1 years respectively.
Key information
Xuefeng Yu
Chief executive officer
CN¥4.0m
Total compensation
CEO salary percentage | 64.1% |
CEO tenure | 15.8yrs |
CEO ownership | 12.0% |
Management average tenure | 6.8yrs |
Board average tenure | 3.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -CN¥720m |
Jun 30 2024 | n/a | n/a | -CN¥867m |
Mar 31 2024 | n/a | n/a | -CN¥2b |
Dec 31 2023 | CN¥4m | CN¥3m | -CN¥1b |
Sep 30 2023 | n/a | n/a | -CN¥1b |
Jun 30 2023 | n/a | n/a | -CN¥2b |
Mar 31 2023 | n/a | n/a | -CN¥1b |
Dec 31 2022 | CN¥5m | CN¥2m | -CN¥909m |
Compensation vs Market: Xuefeng's total compensation ($USD547.05K) is about average for companies of similar size in the Hong Kong market ($USD487.93K).
Compensation vs Earnings: Xuefeng's compensation has been consistent with company performance over the past year.
CEO
Xuefeng Yu (59 yo)
15.8yrs
Tenure
CN¥3,965,000
Compensation
Dr. Xuefeng Yu, Ph D, is Co-Founder of CanSino Biologics Inc. since 2009. Dr. Yu serves as an Executive Director at CanSino Biologics Inc. since January 13, 2009 and has served as its Chief Executive Offic...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 15.8yrs | CN¥3.97m | 11.96% HK$ 1.3b | |
Co-Founder | 15.8yrs | CN¥4.42m | 7.27% HK$ 815.4m | |
Co-Founder | 15.8yrs | CN¥3.74m | 11.42% HK$ 1.3b | |
COO, Deputy GM & Executive Director | 6.5yrs | CN¥3.93m | 0.0081% HK$ 908.3k | |
Chief Commercial Officer | 3.2yrs | CN¥4.57m | 0.0072% HK$ 808.5k | |
Senior Director of New Technology Department | 7yrs | no data | no data | |
Vice President of Marketing | no data | no data | no data | |
Board Secretary | 5.7yrs | no data | no data | |
Joint Company Secretary | 5.7yrs | no data | no data |
6.8yrs
Average Tenure
51yo
Average Age
Experienced Management: 6185's management team is seasoned and experienced (6.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 15.8yrs | CN¥3.97m | 11.96% HK$ 1.3b | |
COO, Deputy GM & Executive Director | 6.4yrs | CN¥3.93m | 0.0081% HK$ 908.3k | |
Chief Commercial Officer | 3.1yrs | CN¥4.57m | 0.0072% HK$ 808.5k | |
Co-Chair of Scientific Advisory Board | 1.8yrs | no data | no data | |
Member of the Scientific Advisory Board | 2.5yrs | no data | no data | |
Independent Non-Executive Director | 5yrs | CN¥300.00k | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Chairman of Employee Representative Supervisor | less than a year | no data | no data | |
Independent Non-Executive Director | 5yrs | CN¥300.00k | 0.00040% HK$ 44.9k | |
Co-Chair of Scientific Advisory Board | 1.8yrs | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Non-Executive Director | no data | no data | no data |
3.1yrs
Average Tenure
59yo
Average Age
Experienced Board: 6185's board of directors are considered experienced (3.1 years average tenure).